Patient Square Capital as of June 30, 2025
Portfolio Holdings for Patient Square Capital
Patient Square Capital holds 19 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Roivant Sciences SHS (ROIV) | 50.7 | $141M | 13M | 11.27 | |
| Insmed Com Par $.01 (INSM) | 13.0 | $36M | 359k | 100.64 | |
| Argenx Se - Sponsored Adr (ARGX) | 5.8 | $16M | 29k | 551.22 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 4.6 | $13M | 1.4M | 9.41 | |
| Liquidia Corporation Com New (LQDA) | 4.6 | $13M | 1.0M | 12.46 | |
| Ocular Therapeutix (OCUL) | 2.7 | $7.6M | 818k | 9.28 | |
| Cullinan Oncology (CGEM) | 2.4 | $6.5M | 869k | 7.53 | |
| Kymera Therapeutics (KYMR) | 2.2 | $6.1M | 140k | 43.64 | |
| Mirum Pharmaceuticals (MIRM) | 2.1 | $5.8M | 114k | 50.89 | |
| Scholar Rock Hldg Corp (SRRK) | 2.0 | $5.5M | 154k | 35.42 | |
| Enliven Therapeutics (ELVN) | 1.8 | $4.9M | 246k | 20.06 | |
| Nurix Therapeutics (NRIX) | 1.7 | $4.7M | 412k | 11.39 | |
| Agios Pharmaceuticals (AGIO) | 1.7 | $4.6M | 140k | 33.26 | |
| Pharvaris N V (PHVS) | 1.5 | $4.3M | 244k | 17.60 | |
| Disc Medicine (IRON) | 1.4 | $3.9M | 74k | 52.96 | |
| Allogene Therapeutics (ALLO) | 1.1 | $3.0M | 2.6M | 1.13 | |
| Geron Corporation (GERN) | 0.4 | $1.0M | 716k | 1.41 | |
| Cidara Therapeutics Com New (CDTX) | 0.3 | $731k | 15k | 48.71 | |
| Vyne Therapeutics (VYNE) | 0.2 | $523k | 317k | 1.65 |
